Sign Up to like & get recommendations! 0
Published in 2022 at "Molecular Genetics & Genomic Medicine"
DOI: 10.1002/mgg3.2099
Abstract: Congenital disorder of glycosylation (CDG) and Glycogen storage diseases (GSDs) are inborn metabolic disorders caused by defects in some metabolic pathways. These disorders are a heterogeneous group of diseases caused by impaired O‐ as well… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Molecular Genetics & Genomic Medicine"
DOI: 10.1002/mgg3.527
Abstract: The diagnostic workup in patients with a clinical suspicion of lysosomal storage diseases (LSD) is often difficult due to the variability in the clinical phenotype. The gold standard for diagnosis of LSDs consists of enzymatic… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Prenatal Diagnosis"
DOI: 10.1002/pd.5547
Abstract: To evaluate the results of prenatal enzymatic diagnostic studies for detecting lysosomal storage diseases (LSDs) during 1992 to 2018. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Herz"
DOI: 10.1007/s00059-019-4824-5
Abstract: In clinical practice cardiac involvement in patients with storage disorders is often diagnosed at a late and advanced stage of the disease with pronounced organ damage. As the currently available targeted therapies can only stop the… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Metabolic brain disease"
DOI: 10.1007/s11011-021-00893-3
Abstract: Whereas significant strides have been made in the treatment of lysosomal storage diseases (LSDs), the neuronopathy associated with these diseases remains impervious mainly because of the blood-brain barrier (BBB), which prevents delivery of large molecules… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Chemical Science"
DOI: 10.1039/c7sc04712f
Abstract: We review pharmacological chaperones used in lysosomal storage diseases, emphasizing medicinal chemistry approaches and mechanisms of action. read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Stem cells and development"
DOI: 10.1089/scd.2021.0304
Abstract: Lysosomal storage diseases (LSD) are inherited metabolic diseases caused due to deficiency of lysosomal enzymes, essential for the normal development of the brain and other organs. Approximately two-thirds of the patients suffering from LSD exhibit… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "ANZ Journal of Surgery"
DOI: 10.1111/ans.17430
Abstract: The skeletal manifestations of lysosomal storage diseases (LSDs) are largely refractory to available therapeutic modalities. Consequently, there is an increasing need to manage their spinal deformities. The aim was to perform a systematic review to… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2018.pa2413
Abstract: Background: The loss of enzymatic activity in lysosomal storage diseases (LSD) results in progressive cellular accumulation of macromolecules. In these patients, respiratory dysfunction is usually a leading cause of morbidity and mortality. Thus, clinical assessments… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Orphanet Journal of Rare Diseases"
DOI: 10.1186/s13023-021-02168-7
Abstract: Background Lysosomal Storage Diseases (LSDs) are a group of Rare Diseases (RDs) caused by lysosomal enzyme deficiencies. Patients with LSDs suffer from a wide range of symptoms with a strong impact in their daily routines.… read more here.
Sign Up to like & get recommendations! 2
Published in 2018 at "Horticultural Science"
DOI: 10.17221/3744-hortsci
Abstract: In the course of a 3-year study the natural occurrence of storage diseases in ambient air storage with 1 to 2°C was evaluated on samples of 30 cultivars and advanced selections that were harvested from… read more here.